COMMUNIQUÉS West-GlobeNewswire

-
Atea Pharmaceuticals Presents Multiple New Datasets Supporting the Combination of Bemnifosbuvir and Ruzasvir for the Treatment of Hepatitis C Virus at AASLD’s The Liver Meeting 2024
15/11/2024 -
Altimmune Presents New Data on the Effect of Pemvidutide on Inflammatory Lipids in Subjects with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) at The Liver Meeting® 2024
15/11/2024 -
CHMP recommends RYBREVANT®▼ (amivantamab) in combination with LAZCLUZE®▼ (lazertinib) for the first-line treatment of patients with EGFR-mutated advanced non-small cell lung cancer
15/11/2024 -
The Testosterone Project Launches on National Testosterone Awareness Day, November 17
15/11/2024 -
Arthritis VIP Founder Dr. Mark Hawass Scoops Prestigious UK ‘Impact Award’
15/11/2024 -
Organogenesis Commends Final LCDs
15/11/2024 -
LogicMark, Inc. Announces Reverse Stock Splits
15/11/2024 -
Trinity Biotech Announces Q3 2024 Financial Results
15/11/2024 -
Outset Medical to Present at the 2024 Stifel Healthcare Conference
15/11/2024 -
Scientific Industries Reports Third Quarter 2024 Financial Results
15/11/2024 -
Scilex Holding Company Announces Presentation of Data at the 2024 American College of Rheumatology Convergence Conference to be held at the Walter E. Washington Convention Center in Washington, D.C. on November 14 – 19, 2024
15/11/2024 -
Crinetics Pharmaceuticals to Participate in Three Upcoming December Investor Conferences
15/11/2024 -
Samsung Bioepis Receives Positive CHMP Opinion for Denosumab Biosimilars, OBODENCE™ and XBRYK™
15/11/2024 -
Sienna Announces November Dividend
15/11/2024 -
Structure Therapeutics to Participate in the Jefferies London Healthcare Conference
15/11/2024 -
Wave Life Sciences to Present at Jefferies London Healthcare Conference
15/11/2024 -
SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer
15/11/2024 -
Safety Shot Expands Retail Footprint with Major Grocery Chain in US Southwest
15/11/2024 -
Biotricity Achieves Improved Margins and Efficiencies, and Year-Over-Year Sales Growth for Second Quarter of Fiscal Year 2025
15/11/2024
Pages